Changeflow GovPing Pharma & Drug Safety EPO Patent Application: Pharmaceutical Formulat...
Routine Notice Added Final

EPO Patent Application: Pharmaceutical Formulation with Echinochrome A Nanofibers

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Pharma (A61K)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published a new patent application, EP4629966A1, concerning a pharmaceutical formulation incorporating echinochrome A within polymeric micro/nanofibers. The application was published on March 18, 2026, and lists the National and Kapodistrian University of Athens as the applicant.

What changed

This document is a publication of a European patent application (EP4629966A1) for a pharmaceutical formulation developed by the National and Kapodistrian University of Athens. The formulation utilizes polymeric micro/nanofibers to incorporate echinochrome A, a compound with potential therapeutic applications. The publication date is March 18, 2026.

As this is a patent application publication, it does not impose direct compliance obligations on regulated entities. However, it signifies potential future developments in drug delivery systems and pharmaceutical innovation. Companies in the pharmaceutical sector should be aware of this publication as it may relate to emerging technologies or competitive intellectual property in the field of echinochrome A-based therapeutics.

Source document (simplified)

← EPO Patent Bulletin

A PHARMACEUTICAL FORMULATION COMPRISING POLYMERIC MICRO-/NANOFIBERS INCORPORATING ECHINOCHROME A

Publication EP4629966A1 Kind: A1 Mar 18, 2026

Applicants

National and Kapodistrian University of Athens

Inventors

ROUSSIS, Vasileios, IOANNOU, Efstathia, KIKIONIS, Stefanos, VALSAMI, Georgia, MAVROGIORGIS, Panagiotis, PAPAKYRIAKOPOULOU, Paraskevi

IPC Classifications

A61K 9/00 20060101AFI20240614BHEP A61K 9/70 20060101ALI20240614BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

A PHARMACEUTICAL FORMULATION COMPRISING POLYMERIC MICRO-/NANOFIBERS INCORPORATING ECHINOCHROME A

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4629966A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Formulation Drug Delivery
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
R&D
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Nanotechnology Drug Delivery

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.